We use some essential cookies to make this website work.
We’d like to set additional cookies to understand how you use GOV.UK, remember your settings and improve government services.
We also use cookies set by other sites to help us deliver content from their services.
You have accepted additional cookies. You can change your cookie settings at any time.
You have rejected additional cookies. You can change your cookie settings at any time.
Departments, agencies and public bodies
News stories, speeches, letters and notices
Detailed guidance, regulations and rules
Reports, analysis and official statistics
Consultations and strategy
Data, Freedom of Information releases and corporate reports
Register to vote Register by 18 June to vote in the General Election on 4 July.
Interim guidance and information on the law for healthcare professionals
The Home Secretary has formally commissioned the Advisory Council on the Misuse of Drugs (ACMD) to conduct a longer-term review of cannabis-based products for medicinal use.
How to account for VAT on goods and services provided by registered health professionals, including doctors, dentists, nurses and pharmacists.
Advice and guidance on the health needs of migrant patients for healthcare practitioners.
The therapeutic and medicinal benefits of cannabis-based products – a review of recent evidence.
Diseases and health problems in sheep and goats, including foot and mouth disease (FMD), scrapie and lead poisoning
Monitoring significant occupational exposures to HIV, hepatitis B and hepatitis C in healthcare workers, and advising on avoiding injuries.
Report examining issues relating to road safety and the use and prescription of medical cannabis.
In July 2007 the Home Secretary requested, in the light of “real public concern about the potential mental health effects of cannabis use, in…
Resources to help local commissioners achieve value for money by estimating the return on investment (ROI) and cost-effectiveness of public health programmes.
Information about controlled drugs licences for companies that possess, manufacture, produce or supply controlled drugs in England, Wales or Scotland.
A guide to farming risks, potential problems with public safety and how to avoid accidents
How to create a model of how your digital health product works and choose measures for your evaluation.
How the MHRA makes decisions on when a product is a medical device (borderline products), and which risk class should apply to a medical device.
Don’t include personal or financial information like your National Insurance number or credit card details.
To help us improve GOV.UK, we’d like to know more about your visit today. Please fill in this survey (opens in a new tab).